SUSCEPTIBILITIES OF BETA-LACTAMASE-POSITIVE AND BETA-LACTAMASE-NEGATIVE STRAINS OF CAMPYLOBACTER-COLI TO BETA-LACTAM AGENTS

被引:23
作者
LACHANCE, N
GAUDREAU, C
LAMOTHE, F
TURGEON, F
机构
[1] HOP ST LUC,SERV MICROBIOL MED & MALAD INFECT,MONTREAL H2X 3J4,QUEBEC,CANADA
[2] UNIV MONTREAL,MONTREAL H2X 3J4,PQ,CANADA
关键词
D O I
10.1128/AAC.37.5.1174
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The percentages of susceptibility of 28 strains of Campylobacter coli to beta-lactam agents were 96% for amoxicillin and ampicillin, 57% for ticarcillin, 4% for cefoxitin and cefuroxime, 61% for cefotaxime, and 11% for ceftazidime. None of the strains were susceptible to penicillin G, piperacillin, cefazolin, cephalothin, cefamandole, and cefoperazone. All strains were susceptible to imipenem and ciprofloxacin, and 21% were susceptible to erythromycin. A beta-lactamase was detected in 68% of the strains by cefinase disks and by the nitrocefin method. The beta-lactamase-positive strains were significantly less susceptible to amoxicillin, ampicillin, and ticarcillin than the beta-lactamase-negative strains (P less-than-or-equal-to 0.003). Clavulanic acid (0.25 mug/ml) but not sulbactam and tazobactam (2 mug/ml) lowered to susceptible levels the amoxicillin and ampicillin MICs of the only strain of C. coli resistant to amoxicillin, ampicillin, and ticarcillin.
引用
收藏
页码:1174 / 1176
页数:3
相关论文
共 17 条
[1]  
BLASER MJ, 1990, PRINCIPLES PRACTICE, P1649
[2]  
BOURGAULT AM, 1979, J CLIN MICROBIOL, V9, P654
[3]   SUSCEPTIBILITY OF CAMPYLOBACTER-JEJUNI AND CAMPYLOBACTER-COLI TO MACROLIDES AND RELATED-COMPOUNDS [J].
ELHARRIF, Z ;
MEGRAUD, F ;
MARCHAND, AM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 28 (05) :695-697
[4]   COMPARATIVE INVITRO ACTIVITIES OF 12 ANTIMICROBIAL AGENTS AGAINST CAMPYLOBACTER SPECIES [J].
FLIEGELMAN, RM ;
PETRAK, RM ;
GOODMAN, LJ ;
SEGRETI, J ;
TRENHOLME, GM ;
KAPLAN, RL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 27 (03) :429-430
[5]   EFFECT OF CLAVULANIC ACID ON SUSCEPTIBILITY OF CAMPYLOBACTER-JEJUNI AND CAMPYLOBACTER-COLI TO 8-BETA-LACTAM ANTIBIOTICS [J].
GAUDREAU, CL ;
LARIVIERE, LA ;
LAUZER, JC ;
TURGEON, FF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (06) :940-942
[6]   COMPARATIVE INVITRO ACTIVITIES OF AZTREONAM, CIPROFLOXACIN, NORFLOXACIN, OFLOXACIN, HR-810 (A NEW CEPHALOSPORIN), RU28965 (A NEW MACROLIDE), AND OTHER AGENTS AGAINST ENTEROPATHOGENS [J].
GOOSSENS, H ;
DEMOL, P ;
COIGNAU, H ;
LEVY, J ;
GRADOS, O ;
GHYSELS, G ;
INNOCENT, H ;
BUTZLER, JP .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 27 (03) :388-392
[7]   ROLE OF THE BETA-LACTAMASE OF CAMPYLOBACTER-JEJUNI IN RESISTANCE TO BETA-LACTAM AGENTS [J].
LACHANCE, N ;
GAUDREAU, C ;
LAMOTHE, F ;
LARIVIERE, LA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (05) :813-818
[8]  
Morris G. K., 1985, MANUAL CLIN MICROBIO, P302
[9]   INHIBITION OF CAMPYLOBACTER-COLI AND CAMPYLOBACTER-JEJUNI BY ANTIBIOTICS USED IN SELECTIVE GROWTH MEDIA [J].
NG, LK ;
STILES, ME ;
TAYLOR, DE .
JOURNAL OF CLINICAL MICROBIOLOGY, 1985, 22 (04) :510-514
[10]   EMERGENCE OF FLUOROQUINOLONE RESISTANCE IN CAMPYLOBACTER-JEJUNI AND CAMPYLOBACTER-COLI IN SUBJECTS FROM FINLAND [J].
RAUTELIN, H ;
RENKONEN, OV ;
KOSUNEN, TU .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (10) :2065-2069